European pharma

South Korea’s biopharmaceutical company Samsung Bioepis Co. won approval from European authorities for sale of Byooviz, its ophthalmology bios...

As concerns rise over a resurgence of the COVID-19 pandemic, the war for talent in South Korea’s pharmaceutical industry is intensifying as th...

South Korean drugmaker Celltrion Inc. has received the Indonesian government’s permission for restricted use of its COVID-19 treatment Regkiro...

Hyundai Motor Co.’s fleet of fuel cell truck XCIENT has surpassed the benchmark one million kilometers of driving in 11 months of service in S...

South Korea will develop its own messenger ribonucleic acid (mRNA) vaccines by next year with plans to annually manufacture 100 million doses from 2...

South Korea’s second-largest automaker Kia Corp. has forged a partnership with Uber Technologies Inc. to supply electric vehicles in Europe fo...

German biopharmaceutical company CureVac N.V. may choose South Korea as one of its global production bases for the COVID-19 vaccine following Korean...

South Korea’s biosimilar and pharmaceutical companies are looking at a growing chance of emerging as a global hub for manufacturing vaccines f...

Shinhan Alternative Investment Management Inc. has committed 200 million euros ($245 million) to a multifamily housing fund in Europe managed by Pat...

Apax Partners is an established, leading private equity firm both in France and in Europe. We are motivated to realise and develop the potential...

Park Square Capital is one of the world’s most established private debt firms, providing flexible financing solutions to high-quality and ...

Tikehau Capital is an asset management and investment group with €25.7 billion of assets under management and shareholder equity of €2...

Hyundai Motor Co. has exported its fuel cell system to non-vehicle startups in Europe, expanding its hydrogen business beyond the automobile industry,...

South Korea is emerging as a global production base for coronavirus vaccines and medicine thanks to its comprehensive production facilities alongside ...